5Indexed trials
drug · Product Intelligence
Gantenerumab
Pipeline Intelligence
Gantenerumab: 5 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT00531804Hoffmann-La Roche · alzheimersPHASE1
NCT02051608Hoffmann-La Roche · alzheimersPHASE3
NCT03443973Hoffmann-La Roche · alzheimersPHASE3
NCT03444870Hoffmann-La Roche · alzheimersPHASE3
NCT04374253Hoffmann-La Roche · alzheimersPHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.